Vesicular monoamine transporter inhibitors versus placebo for antipsychotic-induced tardive dyskinesia

To report the absolute effects of VMAT2 drugs for people with antipsychotic-induced tardive dyskinesia.

This is a protocol.

Health topics:

Published:

22 March 2018

Authors:

Karl B, Bergman H, Abd El Sayed S, Adams CE

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Karl B, Bergman H, Abd El Sayed S, Adams CE. Vesicular monoamine transporter inhibitors versus placebo for antipsychotic-induced tardive dyskinesia. Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012986. DOI: 10.1002/14651858.CD012986